Heartflow (HTFL) Non-Current Deffered Revenue (2024)
Heartflow's quarterly Non-Current Deffered Revenue came in at $413000.0 in Q4 2024.
Heartflow has reported Non-Current Deffered Revenue for 1 years, with the latest figure at $413000.0 in Q4 2024.
- For the quarter ending Q4 2024, Non-Current Deffered Revenue changed N/A year-over-year to $413000.0; the trailing twelve-month figure through Dec 2024 stood at $413000.0 (changed N/A YoY), and the FY2024 full-year result was $413000.0, changed N/A from the prior year.
- Non-Current Deffered Revenue for Q4 2024 stood at $413000.0.
- The five-year high for Non-Current Deffered Revenue was $413000.0 in Q4 2024, with the low at $413000.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | - |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | 4.57 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | - |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | - |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | 400,000.00 |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | 5.16 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | 10.14 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | - |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | 63.07 Mn |
| 10 | Heartflow | 1.15 Bn | 974.90 Mn | 39.06 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 413,000.00 |